<DOC>
	<DOCNO>NCT01991145</DOCNO>
	<brief_summary>This randomize control study aim evaluate efficacy safety allogeneic umbilical cord blood therapy combine erythropoietin child cerebral palsy .</brief_summary>
	<brief_title>Allogeneic UCB Therapy With EPO Children With CP</brief_title>
	<detailed_description>Cerebral palsy ( CP ) group neurodevelopmental condition abnormal movement posture result non-progressive cerebral disturbance . It common cause motor disability childhood . Most therapy palliative rather restorative . Umbilical cord blood ( UCB ) erythropoetin ( EPO ) may use restorative approach child CP . Many experimental animal study reveal UCB beneficial improve repair neurological injury . EPO also know neuroprotective effect . Based animal study clinical trial , UCB suggest potential therapy child CP . EPO combine add synergistic effect UCB therapy .</detailed_description>
	<mesh_term>Cerebral Palsy</mesh_term>
	<mesh_term>Epoetin Alfa</mesh_term>
	<criteria>Diagnosed cerebral palsy Age ≥10 month ≤6 year Mismatch HLAA , B , DR ≤2 , total nucleate cell count ≥3x107/kg . If cell count less give value , 1 unit could use . Hemoglobin ≤13.6 g/dL Decision participation study acquisition inform consent subject 's representative Willingness ability hospitalize accord schedule specify protocol continue study 12 month study entry Current aspiration pneumonia Known genetic disease History hypersensitivity reaction study drug pertinent study History participation study stem cell Prior treatment EPO within 3 month prior study entry Known coagulopathy family history thrombosis medical history recurrent thrombosis Patient severe seizure disease clinical convulsion despite combination therapy 3 agent Uncontrolled hypertension define systolic blood pressure &gt; 115 mmHg and/or diastolic blood pressure &gt; 70 mmHg Hepatic impairment define asparate aminotransferase ( AST ) &gt; 55 IU/L and/or alanine aminotransferase ( ALT ) &gt; 45 IU/L Renal impairment define creatinine ( Cr ) ≥1.2 mg/dL Absolute neutrophil count ≤500/dL Presence diagnose suspect malignant tumor and/or hematologic malignancy Noncompliance study visit specify protocol unwillingness caregiver due lack understanding patient</criteria>
	<gender>All</gender>
	<minimum_age>10 Months</minimum_age>
	<maximum_age>6 Years</maximum_age>
	<verification_date>November 2013</verification_date>
	<keyword>Cerebral Palsy</keyword>
	<keyword>Umbilical Cord Blood</keyword>
	<keyword>Erythropoietin</keyword>
	<keyword>Rehabilitation</keyword>
</DOC>